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Abstract: In bacteria, the DnaG primase is responsible for synthesis of short RNA primers used to
initiate chain extension by replicative DNA polymerase(s) during chromosomal replication. Among
the proteins with which Escherichia coli DnaG interacts is the single-stranded DNA-binding protein,
SSB. The C-terminal hexapeptide motif of SSB (DDDIPF; SSB-Ct) is highly conserved and is known to
engage in essential interactions with many proteins in nucleic acid metabolism, including primase.
Here, fragment-based screening by saturation-transfer difference nuclear magnetic resonance
(STD-NMR) and surface plasmon resonance assays identified inhibitors of the primase/SSB-Ct
interaction. Hits were shown to bind to the SSB-Ct-binding site using 15 N–1 H HSQC spectra.
STD-NMR was used to demonstrate binding of one hit to other SSB-Ct binding partners, confirming
the possibility of simultaneous inhibition of multiple protein/SSB interactions. The fragment
molecules represent promising scaffolds on which to build to discover new antibacterial compounds.
Keywords: antibacterial agents; fragment-based screening; primase; protein–protein interactions; SSB

1. Introduction
Duplication of chromosomal DNA prior to cell division is a fundamental process in living cells.
During initiation of DNA replication in Escherichia coli, DnaB helicase is loaded with the assistance
of the helicase loader DnaC onto double-stranded DNA and unwinds it [1,2]. DnaB, through direct
physical interaction with DnaG primase, forms the primosome [3], which uses its primase activity to
synthesize short RNA primers essential for the function of DNA polymerase III [4,5].
DnaG is a DNA-dependent RNA polymerase [6]. In bacteria it is comprised of three distinct
domains: an N-terminal zinc-binding domain (ZBD) responsible for DNA template recognition [7],
a central catalytic domain (RNA polymerase domain, RPD) [8,9], and a C-terminal helicase-binding
domain (HBD or DnaGC), which is responsible for interaction with DnaB helicase and single-stranded
DNA-binding protein (SSB) [10–12]. The crystal and solution structures of DnaGC of E. coli were
determined by X-ray crystallography as a non-physiological domain-swapped dimer [13] and as a
monomer in solution by NMR spectroscopy [14].
SSB protects single-stranded DNA during DNA replication. It is an interaction hub known to bind
to more than 14 other proteins involved in various stages of DNA replication, repair, and recombination
through a highly conserved C-terminal hexapeptide motif (SSB-Ct, sequence: DDDIPF) [15,16]. SSB’s
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binding partners include DnaG [10,12], the Pol lll χ subunit [12,17–22], the PriA replication restart
helicase [23], and exonuclease I [24,25].
The SSB-Ct binding site in DnaGC has been identified by NMR. The binding pocket is formed by
basic residues K447, R452, and K518, as well as T450, M451, I455, and L519 [26]. Moreover, the DnaGC
point mutants K447A, T450A, R452A, and K518A dramatically attenuate SSB-Ct binding. Mutagenesis
and NMR experiments, in particular 15 N–1 H heteronuclear single-quantum correlation (15 N–1 H HSQC)
experiments suggested that the conserved R452 residue forms a salt bridge with the carboxylic acid of
the C-terminal Phe residue of the SSB-Ct, whereas the other positively charged residues around the
binding pocket interact with the negatively charged residues of SSB-Ct. The SSB-Ct binding pockets in
other SSB-binding proteins have characteristics in common with the binding pocket in DnaGC; e.g.,
those in ExoI [24], RecO [27], Pol lll χ [22], and PriA [23].
The SSB-Ct binding pockets in some or all of these proteins have been suggested to be very good
targets for development of new antibacterial agents because many of the interactions are essential for
bacterial survival and resistance to compounds that interfere with multiple interactions could not easily
develop by target mutagenesis [16]. This argument depends critically on a single compound mimicking
the SSB-Ct peptide sufficiently well that it is able to bind tightly to three or more essential binding
pockets that are lined with different residues and thus have structures that are more or less distinct.
The observed gross structural similarities among pockets in SSB-Ct binding partners, including the
ionic interaction with the C-terminal Phe and the basic rim that interacts with the acidic residues
suggest such compounds might exist, but the only useful way to establish this for sure is to quantify
the binding to multiple potential targets of compounds selected against one of them.
To begin the process of determining whether SSB-Ct binding pockets are actually suitable targets,
we report the use of fragment-based screening (FBS) to find compounds binding to E. coli DnaGC. FBS
uses small (<300 Da) compounds called “fragments” as starting points for drug discovery. Several
biophysical methods may be used in fragment screening [28]. Here, we report the use of surface
plasmon resonance (SPR) and NMR measurements to screen for binders that target the SSB-binding
pocket in DnaGC.
2. Results and Discussion
2.1. Screening of Fragment Libraries
An SPR competition assay (example in Figure S1a) was used as the first-pass screen. It identified
six small-molecule fragments that competed with immobilized SSB-Ct peptide for binding to a
N-terminally truncated DnaG protein missing just the ZBD; we call this protein DnaG-RCD, comprised
of the RPD and DnaGC domains. These fragments were validated by saturation-transfer difference
(STD) NMR [29], where transient binding of the ligand to the protein is detected by attenuation of
the ligand NMR spectrum (example in Figure S1b). In parallel with the confirmation of SPR hits,
cocktails encompassing the complete MIPS library of 1140 structurally diverse fragments [30] were
independently screened by STD-NMR. Fragments identified in cocktails were re-tested as pure ligands
in the STD-NMR assay. The hits identified were ranked according to STD signal intensity. In total,
56 fragments were identified as top hits (rank 3, clear hit, strong intensity difference) and 62 as
rank 2 (clear hit, moderate intensity) [30]. From the final STD rank 3 and 2 compounds together
(80 compounds), about 50 fragments were identified as “frequent hits” or “PAINS” [30] and were
excluded from further screening.
2.2. Validation of Fragment Binding by 2D NMR
Two-dimensional (2D) 15 N–1 H HSQC spectra of the uniformly 15 N-labeled DnaGC domain were
employed to validate STD hits. Buffer conditions were optimized, and no major differences were
observed in recorded spectra of the protein alone compared to the original studies [13,14]. We were
able to assign some of the missing resonances for residues forming the SSB-Ct binding pocket in
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In the case of fragment 1, CSP-guided docking predicts that the carbonyl group interacts with
In the case of fragment 1, CSP-guided docking predicts that the carbonyl group interacts with
the side-chain of R452. The fragment orientation enables favorable contact of the free carboxylate of
the side-chain of R452. The fragment orientation enables favorable contact of the free carboxylate of
the fragment and the positively charged side chain of K518 (Figure S4). Its improved binding affinity
the fragment and the positively charged side chain of K518 (Figure S4). Its improved binding affinity
(~1.1 mM) is most likely explained by its hydrophobic skeleton occupying the shallow binding
(~1.1 mM) is most likely explained by its hydrophobic skeleton occupying the shallow binding pocket.
pocket. Comparison of fragment 1 with an analog where the carboxylate is substituted with a methyl
Comparison of fragment 1 with an analog where the carboxylate is substituted with a methyl group
group gave fewer peak shifts in the HSQC spectrum, confirming that the carboxylic acid group
gave fewer peak shifts in the HSQC spectrum, confirming that the carboxylic acid group improves the
improves the binding (Figure S5).
binding (Figure S5).
Fragments 2 and 3 have similar aliphatic chains with thioether links to aromatic groups. As with
Fragments 2 and 3 have similar aliphatic chains with thioether links to aromatic groups. As with
other fragments, the carboxylate moieties are predicted to form electrostatic and hydrogen bond
other fragments, the carboxylate moieties are predicted to form electrostatic and hydrogen bond
interaction, whereas the main chemical backbone mimics the phenylalanine residue in SSB-Ct.
interaction, whereas the main chemical backbone mimics the phenylalanine residue in SSB-Ct.
Thioethers may have a strong influence on the conformation of aliphatic chains [37]. In the proposed
Thioethers may have a strong influence on the conformation of aliphatic chains [37]. In the proposed
binding mode of fragment 3, the sulfur atom interacts with R452 while the carboxylate forms
binding mode of fragment 3, the sulfur atom interacts with R452 while the carboxylate forms hydrogen
hydrogen bonds with I455 and G481 (Figure S6).
bonds with I455 and G481 (Figure S6).
One of the fragments tested, N-acetylated L-Phe, is expected to mimic the C-terminal residue
One of the fragments tested, N-acetylated L-Phe, is expected to mimic the C-terminal residue
(F177) in the SSB-Ct peptide. STD and 15N–1H HSQC experiments confirmed the binding event (data
(F177) in the SSB-Ct peptide. STD and 15 N–1 H HSQC experiments confirmed the binding event (data
not shown). However, binding affinities measured in titration experiments monitored by HSQC
not shown). However, binding affinities measured in titration experiments monitored by HSQC
spectra showed that it has about two-fold lower affinity compared to other hits (3, 4). The modeled
spectra showed that it has about two-fold lower affinity compared to other hits (3, 4). The modeled
orientations of the fragment show indeed that the phenyl ring forms hydrophobic contacts in the
binding site, and the carboxylate interacts with R452 (Figure S7). Substituting the carboxylate with a
1H-tetrazole ring, as found in fragment 4, increased the affinity 2-fold.
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The observed NMR peak shifts were consistent with the docked orientation. The negatively
The observed NMR peak shifts were consistent with the docked orientation. The negatively
charged tetrazole is predicted to form favorable electrostatic and hydrogen bond interactions with
charged tetrazole is predicted to form favorable electrostatic and hydrogen bond interactions with the
the side chains of K447 and R452. The methyl groups of L446, M451, L455, L484 T515 and L519 form
side chains of K447 and R452. The methyl groups of L446, M451, L455, L484 T515 and L519 form a
a hydrophobic pocket accommodating two aromatic rings of the compound. One of the fluorine
hydrophobic pocket accommodating two aromatic rings of the compound. One of the fluorine atoms
atoms is about 3 Å from the amide group of G481 while the second at the para-position of the phenoxy
is about 3 Å from the amide group of G481 while the second at the para-position of the phenoxy group
group points out of the pocket toward K518. In the docked conformation, these fluorine atoms are
points out of the pocket toward K518. In the docked conformation, these fluorine atoms are involved
involved in hydrogen bond formation with these two residues (Figure 4). To test the docked
in hydrogen bond formation with these two residues (Figure 4). To test the docked orientation of 5,
orientation
of 5, 1D 19F-NMR was carried out using a 20-fold excess of compound over protein.
1D 19 F-NMR was carried out using a 20-fold excess of compound over protein. Fluorine signals were
Fluorine signals were broadened and shifted slightly downfield, confirming binding of 5 to DnaGC
broadened and shifted slightly downfield, confirming binding of 5 to DnaGC (Figure 5). Nevertheless,
(Figure 5). Nevertheless,
the 3D NOESY-15N-HSQC spectrum failed to detect any protein–ligand
the 3D NOESY-15 N-HSQC spectrum failed to detect any protein–ligand NOEs.
NOEs.
Compound 5 was shown to bind to DnaGC with about a three-fold improved affinity compared
Compound 5 was shown to bind to DnaGC with about a three-fold improved
affinity compared
to the starting fragment 4, as measured by titration experiments monitored by 15 N–1 H HSQC spectra
15
to the starting fragment 4, as measured by titration experiments monitored by N–1H HSQC spectra
(KD = 1.3 mM). Searching the ZINC database [38] for ligands structurally similar to 5 indicated that the
(KD = 1.3 mM). Searching the ZINC database [38] for ligands structurally similar to 5 indicated that
only available analog was 6. It is missing the halogen atoms and has a meta-phenoxy group (Figure 6).
the only available analog was 6. It is missing the halogen atoms
and
a meta-phenoxy group (Figure
1 H has
The binding of 6 to DnaGC was also assessed by STD and 15 N–
HSQC experiments (Figure 6).
15
1
6). The binding of 6 to DnaGC was also assessed by STD and N– H HSQC experiments (Figure 6).
Compounds 5 and 6 showed similar patterns of CSPs (Figure S3e,f). Compounds that possess
Compounds 5 and 6 showed similar patterns of CSPs (Figure S3e,f). Compounds that possess
similar protein-binding modes are known to induce similar CSPs [39]. Changes in the position of the
similar protein-binding modes are known to induce similar CSPs [39]. Changes in the position of the
phenoxy group in 6 relative to 5 increased the magnitude of the CSP as a result of a slightly improved
binding affinity, KD = 1.2 mM.
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Compounds that bound non-specifically to the chip surface were excluded from screening. A flow rate
of 5 µL/min was used during the 60 s injection and 60 s dissociation phases for all experiments.
3.4. Saturation-Transfer Difference (STD) NMR Spectroscopy
STD-NMR experiments were carried out using 5 µM unlabeled DnaG-RCD and mixtures of
6 fragments in each sample, at ~250 µM for each fragment. The sample volume was 500 µL with
98–99% 2 H2 O buffer containing 50 mM phosphate (pH 7.8), 50 mM NaCl and 1 mM dithiothreitol.
Spectra were recorded at 283 K using a Bruker Avance 600 MHz spectrometer (Bruker, Karlsruhe,
Germany) equipped with a cryoprobe. Saturation of protein was achieved with a 4 s Gaussian pulse
sequence train centered at −1 ppm. For reference spectra, a similar saturation pulse was applied
20 kHz off-resonance. A 20 ms spin-lock period was applied before acquisition to allow the residual
protein signals to decay. The STD experiments were recorded over 64 scans. All NMR data were
processed using TOPSPIN 3.1. Relative intensities were based on the most intense STD signal (Imax )
identified across all STD spectra. A positive STD signal was categorized as “strong”, “moderate” or
“weak” where the intensity was >50%, >25% or <25% of Imax , respectively [30].
3.5. 2D 15 N–1 H HSQC Spectra
Protein binding by compounds identified by SPR and STD screens was confirmed by recording
HSQC spectra on uniformly 15 N-labeled DnaGC (100 µM) in the presence of 3.3 mM
compounds (from 2 H6 -DMSO stocks) with HSQC buffer (50 mM MES pH 6.0, 60 mM NaCl, 1 mM
dithiothreitol) containing 3% 2 H2 O. The final volume of each sample was 150 µL. The recording
time was 30 min for each 15 N–1 H HSQC experiment. A standard pulse sequence was used for data
acquisition. Spectra were recorded at 298 K with a Bruker Avance 600 MHz NMR spectrometer
equipped with cryoprobe and auto-sample changer. Compounds were regarded as hits if chemical
shift perturbation was observed in the 15 N–1 H HSQC spectra. The spectra were processed with
TOPSPIN 3.1 and analyzed using CCPN [43]. Weighted CSP values [44] were calculated as

15 N–1 H

CSP = (∆δH 2 + 0.2 ∆δN 2 )0.5
Binding affinities were estimated by incremental titration of fragments into protein, with recording
of a 15 N–1 H HSQC experiment at each concentration point. Compound solubilities were tested to
determine the highest concentrations of ligands used in assays. Equilibrium dissociation constants
from NMR titration data were derived using the “single site-specific binding with ligand depletion”
model in GraphPad Prism v.6.0 (La Jolla, CA, USA).
3.6.

19 F-NMR

Spectroscopy

1D 19 F-NMR spectra were recorded on a Bruker Avance III 400 MHz NMR spectrometer (Bruker,
Karlsruhe, Germany) equipped with the two-channel BBO probe with z-gradient at 300 K. All 19 F-NMR
spectra were recorded with 256 scans for fragment and complex samples sequentially. Fragments
dissolved in 2 H6 -DMSO were diluted in HSQC buffer to give final fragment and protein concentrations
of 1 mM and 50 µM, respectively.
3.7. Molecular Docking
AutoDock Tools 1.5.6 [45] was used to prepare protein [46] and ligand structures for docking.
The protonation state of the titratable groups in the protein were assigned at pH 7.0 using PROPKA
3.1 [47]. Polar hydrogen atoms and atom-based Gasteiger partial charges were added. Nonpolar
hydrogen atoms were merged with the parent atom. The DnaGC structure was taken from the
previously solved crystal structure (PDB ID: 1T3W) [13]. The protein was treated as a rigid body.
The CSP docking calculations were performed using AutoDock Vina 1.1.2 [45]. The calculations
utilized an exhaustiveness of 1024 with grid points separated by 1.0 Å and grid size large enough to
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include the SSB-Ct peptide binding site (16 × 16 × 14 Å). Ligand data were obtained from the ZINC
database of commercially available compounds [38].
4. Conclusions
Fragment-based screening has successfully identified compounds targeting the DnaG primase
and its SSB-Ct interaction. Compounds containing indole and 1H-tetrazole scaffolds were identified as
first-generation hits. Based on CSP-guided molecular modeling studies, they are involved in formation
of various electrostatic and hydrogen bond networks in the binding pockets, which makes them
promising starting points for further optimization. Initial in silico fragment-to-lead optimization
was carried out using the ZINC Database. Para-phenyl substituted tetrazoles were identified.
The observation that compounds selected for binding to the C-terminal domain of DnaG primase
also bind to other SSB-interacting proteins indicates that compounds may in future be derived that
bind to similar binding pockets in multiple protein targets, which is a prerequisite for development of
antibacterial compounds with a very low propensity for development of resistance.
Supplementary Materials: The following are available online at www.mdpi.com/2079-6382/7/1/14/s1,
Figure S1. Surface plasmon resonance (SPR) competition sensorgram for one of the SPR hits, and saturation
transfer difference (STD)-NMR spectrum of SPR hit D6; Figure S2. 15 N–1 H HSQC spectra of DnaGC protein with
and without fragment hits 1–3; Figure S3. Residue-specific weighted chemical shift perturbations induced in
15 N-DnaGC by binding to compounds 1–6; Figure S4. Modeled orientation of fragment 1; Figure S5. Comparison
of chemical shift perturbation (CSP) induced by fragment 1 and compound L1C6; Figure S6. Modeled orientation
of fragment 3; Figure S7. Modeled orientation of N-acetyl-L-Phe (green carbon atoms) in the SSB-Ct binding
pocket of DnaGC (gray carbon atoms). Figure S8. STD NMR spectrum of fragment 4 with four SSB-Ct binding
partners other than DnaG primase.
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